AAM
KDNY

Alpine Associates Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Alpine Associates Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,131,000
Closed -$81.9M – 49
2023
Q2 		$81.9M Buy
+2,131,000
New +$81.9M 3.69% 11